118 related articles for article (PubMed ID: 7801332)
1. Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazole.
Whitehouse LW; Menzies A; Mueller R; Pontefract R
Toxicology; 1994; 94(1-3):81-95. PubMed ID: 7801332
[TBL] [Abstract][Full Text] [Related]
2. Hepatic effects of ketoconazole in the male Swiss Webster mouse: temporal changes in drug metabolic parameters.
Whitehouse LW; Pakuts AP; Paul CJ; Mueller RW; Thomas BH
Can J Physiol Pharmacol; 1990 Aug; 68(8):1136-42. PubMed ID: 2390740
[TBL] [Abstract][Full Text] [Related]
3. Ketoconazole-induced hepatic lysosomal phospholipidosis: the effect of concurrent barbiturate treatment.
Pakuts AP; Parks RJ; Paul CJ; Bujaki SJ; Mueller RW
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):55-62. PubMed ID: 2326549
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
[TBL] [Abstract][Full Text] [Related]
5. Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity.
Fukami T; Iida A; Konishi K; Nakajima M
Biochem Pharmacol; 2016 Sep; 116():153-61. PubMed ID: 27422753
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro inhibition of hepatic microsomal drug metabolism by ketoconazole.
Mosca P; Bonazzi P; Novelli G; Jezequel AM; Orlandi F
Br J Exp Pathol; 1985 Dec; 66(6):737-42. PubMed ID: 3936532
[TBL] [Abstract][Full Text] [Related]
7. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatic metabolites of ketoconazole: isolation and structure elucidation.
Whitehouse LW; Menzies A; Dawson B; Cyr TD; By AW; Black DB; Zamecnik J
J Pharm Biomed Anal; 1994 Nov; 12(11):1425-41. PubMed ID: 7849138
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic doses of ketoconazole affect expression of a subset of hepatic genes.
Casley WL; Ogrodowczyk C; Larocque L; Jaentschke B; LeBlanc-Westwood C; Menzies JA; Whitehouse L; Hefford MA; Aubin RA; Thorn CF; Whitehead AS; Li X
J Toxicol Environ Health A; 2007 Nov; 70(22):1946-55. PubMed ID: 17966066
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases.
Rodriguez RJ; Acosta D
Drug Metab Dispos; 1997 Jun; 25(6):772-7. PubMed ID: 9193882
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole.
Khoo SM; Porter JH; Edwards GA; Charman WN
J Pharm Sci; 1998 Dec; 87(12):1538-41. PubMed ID: 10189263
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
[TBL] [Abstract][Full Text] [Related]
14. Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes.
Rodriguez RJ; Proteau PJ; Marquez BL; Hetherington CL; Buckholz CJ; O'Connell KL
Drug Metab Dispos; 1999 Aug; 27(8):880-6. PubMed ID: 10421614
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
16. Critical ketoconazole dosage range for ciclosporin clearance inhibition in the dog.
Myre SA; Schoeder TJ; Grund VR; Wandstrat TL; Nicely PG; Pesce AJ; First MR
Pharmacology; 1991; 43(5):233-41. PubMed ID: 1784623
[TBL] [Abstract][Full Text] [Related]
17. The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the rat.
Thomson RG; Rawlins MD; James OF; Wood P; Williams FM
Biochem Pharmacol; 1988 Oct; 37(20):3975-80. PubMed ID: 3190741
[TBL] [Abstract][Full Text] [Related]
18. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.
Lehman-McKeeman LD; Johnson DR; Caudill D
Toxicol Appl Pharmacol; 1997 Jan; 142(1):169-77. PubMed ID: 9007046
[TBL] [Abstract][Full Text] [Related]
19. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes.
Rodriguez RJ; Acosta D
Toxicology; 1997 Feb; 117(2-3):123-31. PubMed ID: 9057891
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor dependent and independent activities of testosterone on hepatic microsomal drug metabolism.
Brown TR; Greene FE; Bardin CW
Endocrinology; 1976 Nov; 99(5):1353-62. PubMed ID: 991826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
